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ABSTRACT
Nicotine binds to and activates a family of ligand-gated ion channels, neuronal nicotinic acetylcholine receptors (nAChRs).
Chronic nicotine exposure alters the expression of various nAChR subtypes, which likely contributes to nicotine dependence;
however, the underlying mechanisms regulating these changes remain unclear. A growing body of evidence indicates that
microRNAs (miRNAs) may be involved in nAChR regulation. Using bioinformatics, miRNA library screening, site-directed
mutagenesis, and gene expression analysis, we have identified a limited number of miRNAs that functionally interact with
the 3′-untranslated regions (3′ UTRs) of mammalian neuronal nAChR subunit genes. In silico analyses revealed specific,
evolutionarily conserved sites within the 3′ UTRs through which the miRNAs regulate gene expression. Mutating these
sites disrupted miRNA regulation confirming the in silico predictions. In addition, the miRNAs that target nAChR 3′ UTRs
are expressed in mouse brain and are regulated by chronic nicotine exposure. Furthermore, we show that expression of one
of these miRNAs, miR-542-3p, is modulated by nicotine within the mesocorticolimbic reward pathway. Importantly,
overexpression of miR-542-3p led to a decrease in the protein levels of its target, the nAChR β2 subunit. Bioinformatic analysis
suggests that a number of the miRNAs play a general role in regulating cholinergic signaling. Our results provide evidence for
a novel mode of nicotine-mediated regulation of the mammalian nAChR gene family.
Keywords: nicotinic acetylcholine receptor; miRNA analysis; gene expression; miR-542-3p
INTRODUCTION
Despite considerable educational and legislative efforts, to-
bacco use remains the single most avoidable cause of death
in the world (WHO 2009). At the molecular level, nicotine,
the addictive component of tobacco, initiates dependence
by binding to and activating neuronal nicotinic acetylcholine
receptors (nAChRs), which are normally activated by the
endogenous neurotransmitter acetylcholine (ACh) (Albu-
querque et al. 2009; Improgo et al. 2010). Activation of the re-
ceptors in the dopaminergic mesocorticolimbic reward
pathway is thought to underlie the initiation of dependence
whereas signaling through nAChRs in the habenulo-inter-
peduncular pathway that feeds into the reward pathway is
thought to play a key role in eliciting nicotine-associated
withdrawal symptoms (Albuquerque et al. 2009; Salas et al.
2009; Zhao-Shea et al. 2013). Neuronal nAChRs are a family
of ligand-gated cation channels signaling through which
underlies a variety of fundamental physiological processes
(Dani 1993, 2001). To date, 11 distinct mammalian neuronal
nAChR subunits have been identified (α2–α7, α9, α10, and
β2–β4). Five subunits coassemble to form functional recep-
tors with the subunit composition defining the pharmaco-
logical and biophysical properties of each nAChR subtype
(Corringer et al. 2000). Heteromeric nAChRs, consisting
of two or three α subunits and two or three β subunits,
have high affinities (nanomolar concentrations) for nicotine
whereas homomeric nAChRs, the predominant subtype con-
taining α7 subunits, have relatively low affinities (μM con-
centrations) for nicotine (Cooper et al. 1991; McGehee and
Role 1995; Leonard and Bertrand 2001). Given there are
11members of the nAChR subunit family, the potential
for a substantial variety of functionally distinct nAChR
subtypes exists. This functional diversity is a consequence
of the molecular mechanisms that dictate the availability of
nAChR subunits in the appropriate cellular contexts and
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the appropriate developmental stages. While a substantial
effort has been put forth to understand these mechanisms
(Albuquerque et al. 2009), they remain to be completely
elucidated.
In addition to activating nAChRs, nicotine also causes
an increase in high affinity nicotine-binding sites following
chronic exposure (Marks et al. 1983; Benwell et al. 1988;
Flores et al. 1992); however, the underlying mechanisms
leading to the up-regulation remain unclear, although tran-
scriptional mechanisms are not thought to be involved
(Marks et al. 1992). Regardless, all models must account
for a change in the levels of available nAChR protein leading
to changes in the biophysical and ligand-binding properties
of the receptors (Albuquerque et al. 2009; Govind et al.
2009). Several levels of regulation underlying nicotine-in-
duced changes in nAChR subtypes could potentially exist.
These include changes in receptor protein levels, assembly,
conformation, stoichiometry, and/or turnover. Evidence
exists for all of these (Peng et al. 1994; Nashmi et al. 2003;
Nelson et al. 2003; Darsow et al. 2005; Ficklin et al. 2005;
Sallette et al. 2005; Vallejo et al. 2005; Moroni et al. 2006;
Rezvani et al. 2007; Walsh et al. 2008; Govind et al. 2009,
2012; Srinivasan et al. 2011; Columbo et al. 2013), supporting
the idea that it is not likely that any single mechanism exclu-
sively accounts for all the observed changes in nAChR sub-
type expression during or after chronic nicotine exposure.
A growing body of evidence indicates that nicotine and
cigarette smoke alter the expression of small 21–24-nt long
regulatory molecules referred to as microRNAs (miRNAs).
miRNAs are predicted to regulate themajority of all mamma-
lian protein coding genes (Friedman et al. 2009; Ghildiyal
and Zamore 2009; Ameres and Zamore 2013). These regula-
tory molecules are particularly abundant in the brain and
play important roles in several aspects of nervous system de-
velopment (Cao et al. 2006; Bicker and Schratt 2008; Fiore
et al. 2008). miRNAs typically function by guiding a target
mRNA to an RNA-induced silencing complex (RISC), which
causes either inhibition of translation or mRNA degradation
(Friedman et al. 2009; Ghildiyal and Zamore 2009). How-
ever, miRNAs can also cause an increase in target gene ex-
pression (Vasudevan et al. 2007). Interestingly, miRNAs are
regulated by nicotine and/or tobacco smoke in several tissues
and cell lines. For example, Balaraman et al. (2012) demon-
strated that treatment of cerebral cortical-derived neuro-
spheres with nicotine, at concentrations similar to those
attained by cigarette smokers, induced a dose-related increase
in the expression of several miRNAs, an effect that is blocked
by the nonselective nAChR antagonist, mecamylamine. In-
terestingly, given the comorbidity of nicotine dependence
and alcohol abuse, three of the miRNAs regulated by nicotine
are also ethanol-sensitive (Balaraman et al. 2012). In another
study, miRNA analysis of airway epithelium of smokers com-
pared with nonsmokers demonstrated significant differences
in miRNA expression (Schembri et al. 2009). The lungs of
rats exposed to cigarette smoke displayed a change in expres-
sion of 126 miRNAs (Izzotti et al. 2009). In addition, nicotine
alters miRNA expression levels in canine atrial fibroblasts
(Shan et al. 2009) and a rat pheochromocytoma cell line,
PC12 (Huang and Li 2008). Furthermore, a recent study
demonstrated regulation of miRNA expression by nicotine
in adult mouse brain (Lippi et al. 2011). With respect to
nAChR expression, it has been demonstrated that miR-1 reg-
ulates translation of two nAChR subunits, UNC-29 and
UNC-63, in the body muscles of Caenorhabditis elegans,
which leads to changes in the functional properties of the
mature nAChR receptors (Simon et al. 2008). More recently,
Gallego et al. (2013) showed that over-expression of miR-
138 down-regulated reporter gene expression in constructs
containing the nAChR β4 subunit 3′-untranslated region
(3′ UTR) that includes a potential miR-138-binding site.
To the best of our knowledge, however, there are no reports
demonstrating the role of miRNAs in regulating endogenous
mammalian neuronal nAChR expression.
Here, we report a miRNAome analysis of the mammali-
an neuronal nAChR family. We demonstrate that a subset
of miRNAs regulates gene expression via functional inter-
actions with miRNA recognition elements (MREs) in the 3′
UTRs of mammalian nAChR receptor subunit genes. Fur-
thermore, we show that several of these miRNAs are regulat-
ed by chronic nicotine exposure in the mammalian brain.
Finally, we demonstrate that overexpression of one of the
miRNAs, miR-542-3p, led to a decrease in the protein levels
of its target, the nAChR β2 subunit. Our findings provide ev-
idence for a novel mode of nAChR regulation that is likely to
be relevant to the molecular underpinnings of nicotine-asso-
ciated behaviors.
RESULTS AND DISCUSSION
A miRNA library screen identifies a limited
number of miRNAs as potential regulators
of nAChR expression
Using three algorithms, Targetscan (Lewis et al. 2005), Mi-
crocosm Targets (Griffiths-Jones et al. 2008), and miRDIP
(Shirdel et al. 2011), we detected a large number of potential
MREs for a wide variety of miRNAs in the 3′ UTRs of the
11 mammalian neuronal nAChR subunit genes (data not
shown). To systematically investigate whether any of these
miRNAs may regulate gene expression via interactions with
the nAChR 3′ UTRs, we performed a large-scale in vitro
screen wherein we coexpressed, in HEK293T cells, luciferase
reporter constructs containing each nAChR subunit 3′ UTR
with each miRNA precursor mimic from a mouse miRNA
precursor library (see Materials and Methods for details).
As expected, the majority of miRNAs coexpressed with the
luciferase/nAChR constructs did not alter reporter gene ac-
tivity (Supplemental Fig. 1). Interestingly, however, a limited
number of miRNAs did affect expression of the luciferase/
nAChR 3′-UTR constructs. A subset of miRNAs caused
miRNA regulation of nAChR subunit genes
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significant decreases in luciferase activity while another gave
rise to significant increases in luciferase activity (Supplemen-
tal Fig. 1). The changes in luciferase activity ranged from a
∼60% decrease to a ∼80% increase. We focused on those
miRNAs that led to a significant repression of luciferase ac-
tivity as that is the primary mode of regulation by most
miRNAs (Ambros 2004; Bartel 2009; Thomas et al. 2010).
We have not pursued the miRNAs that increased luciferase
activity. A secondary screen was carried out to confirm the
results of the primary screen and identified 27 miRNAs
that down-regulated luciferase/nAChR expression (Supple-
mental Table 1).
Site-directed mutagenesis of nAChR subunit
3′-UTR miRNA binding sites
miRNAs regulate gene expression via interactions with MREs
and can function in a combinatorial manner if an mRNA
transcript contains multiple MREs (Sal-
mena et al. 2011). Using TargetScan,
Microcosm Targets, and miRDIP, we
identified 249 potential MREs in the
nAChR 3′ UTRs representing potential
binding sites for all 27 miRNAs that
came through the miRNAome screen
(Supplemental Table 1). The majority
of these MREs (223), however, are pre-
sent in nAChR 3′ UTRs that did not,
in the HEK293T system, functionally in-
teract with the corresponding miRNAs
(Supplemental Table 1, □). It is possible
that such miRNAs may regulate nAChR
expression in a different cellular context.
For the remaining 26 potential MREs,
site-directed mutagenesis was performed
to determine whether any of them are
necessary for miRNA regulation in our
system. As shown in Figure 1 and Sup-
plemental Table 1 (S), mutation of 16
of the 26 MREs resulted in derepression
of miRNA regulation of luciferase acti-
vity. In one case, nAChR α6/miR-7a,
mutation of two MREs was necessary
for derepression (Fig. 1). In nine cases,
mutation of an MRE had no effect on
miRNA regulation of the luciferase/
nAChR 3′-UTR constructs (Supplemen-
tal Table 1, R). In summary, we identi-
fied 27 miRNAs that regulate expression
of luciferase/nAChR 3′-UTR reporter
constructs with 14 of these miRNAs re-
quiring an intact MRE to exert their reg-
ulatory effects. Finally, there were nine
cases representing eight miRNAs in
which miRNA regulation was seen but
for which no MREs were identified in the nAChR 3′ UTRs
(Supplemental Table 1, checkmarks) possibly indicating
that the miRNAs regulate gene expression indirectly or that
they bind to as yet unidentified MREs.
Conservation of MREs between human and mouse
nAChR 3′ UTRs
Among the 14 mouse miRNAs that functioned via canon-
ical MREs in the luciferase/nAChR 3′-UTR experiments
presented in Figure 1, 10 have human homologs (miR-494,
miR-346, miR-491, miR-7a, miR-208, miR-490-3p, miR-
542-3p, miR297b, miR-374-3p, and miR-668) while four
do not (miR-667, miR-688, miR-698, and miR-704). We
used miRbase to investigate whether any of the latter four
miRNAs have human orthologs. Three of them, miR-688,
miR-698, and miR-704, do not, however, rodent miR-667
is homologous to human miR-766.
FIGURE 1. miRNAs act through predicted MREs in the nAChR 3′ UTRs. Predicted MREs in the
indicated nAChR 3′ UTRs were disrupted via site-directed mutagenesis (mutated nucleotides are
shown in red) and assayed for miRNA-mediated repression of luciferase activity as described in
Supplemental Figure S1. Each bar represents the normalized luciferase activity assayed from
HEK293T cells transfected with the indicated luciferase/nAChR 3′-UTR construct and a
miRNA precursor mimic, or negative control miRNA precursor mimic (n = 3–6). Data are pre-
sented as mean ± SEM. P-values compared with a negative miRNA control derived from the
Student’s t-test are indicated. The types of seed match sites (binding sites corresponding to the
miRNA seed region) are indicated.
Hogan et al.
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With respect to the nAChR subunits, we found MREs for
miR-7a, miR-491, miR-494, miR-542-3p, miR-668, and
miR-766 in human nAChR subunit 3′ UTRs (Fig. 2).
Interestingly, there are five miR-491 MREs in the β2 3′
UTR and two miR-668 MREs in the α4 3′ UTR (Fig. 2).
The significance of multiple MREs for a given miRNA in a
human nAChR 3′ UTR remains to be determined but may
be reminiscent of mouse miR-7a regulation of the lucifer-
ase/nAChR α6 3′-UTR construct in which both miR-7a
MREs had to be mutated in order for derepression to be
observed (Fig. 1). Using Multiple Sequences Alignment
(MUSCLE), we identified three miRNAs, miR-494, miR-
542-3p, and miR-667/766 that have conserved MREs in the
corresponding mouse and human nAChR subunit 3′ UTRs.
Specifically, the mouse and human α4 nAChR subunit 3′
UTRs both share seed match sites for miR-494 and miR-
667/766, whereas the mouse and human β2 nAChR subunit
3′ UTRs both share seed match sites for miR-542-3p (data
not shown), which, as shown below, regulates endogenous
β2 subunit expression. Conservation of MREs in the α4
and β2 subunits is particularly intriguing as these two sub-
units co-assemble to form the predominant nicotine high-af-
finity nAChR subtype expressed in the brain and as such, is a
common target for smoking cessation drug discovery (e.g.,
varenicline, Coe et al. 2005). The MREs for the other three
miRNAs (miR-7a, miR-491, andmiR-668) are present in dif-
ferent nAChR 3′ UTRs in humans as compared with mouse.
That is to say, miR-7a MREs are found in human nAChR α9,
α10, β2, and β4 3′ UTRs, where in mouse it is present in the
α6 3′ UTR. miR-491 MREs are present in human nAChR α2,
α10, and β2 3′ UTRs, where in mouse the miR-491 MRE is
present in the α5 3′ UTR. miR-668 MREs are found in hu-
man nAChR α2, α4, and β2 3′ UTRs while in mouse it is
seen in the β3 3′ UTR.
We were intrigued by the conservation of miR-494, miR-
542-3p, andmiR-667/766MREs in the corresponding mouse
and human nAChR 3′ UTRs and asked whether genes encod-
ing other components of the cholinergic signaling pathway
contain similarly conserved MREs in their 3′ UTRs. Rather
interestingly, a Targetscan analysis revealed the presence of
miR-494, miR-542-3p and miR-667/766 MREs in a variety
of mouse and human genes encoding a number of key players
in cholinergic signaling including choline transporters, cho-
linesterases and nAChR subunit chaperone proteins (Sup-
plemental Table 2). The physiological significance of these
MREs awaits further study but their presence supports a
hypothesis in which a limited number of miRNAs coordi-
nately regulate a family of genes whose products work to-
gether to effect cholinergic signaling and may suggest novel
drug targets for pathologies in which cholinergic signaling
is compromised.
miRNA expression analysis
The miRNAome analysis presented above identified 27
miRNAs that down-regulated luciferase/nAChR expression
in HEK293T cells (Supplemental Fig. S1 and Supplemental
Table 1) leading to the hypothesis that these miRNAs regulate
nAChR expression in the brain. Consistent with this hypoth-
esis, quantitative reverse-transcription-PCR (qRT-PCR) was
used to demonstrate expression of the miRNAs in the brain
with the exception of miR-208 and miR-374-3p, which
were not detected at all (data not shown). It is possible that
miR-208 andmiR-374-3p regulate nAChR expression in oth-
er tissues as the nAChR family is known to be expressed
throughout the body (Albuquerque et al. 2009).
A logical extension of the hypothesis just presented is that
the candidate miRNAs regulate neuronal nAChR expression
in response to nicotine treatment. It follows, then, that the
miRNAs themselves are regulated by nicotine and further,
if miRNA regulation plays a role in the well documented
nicotine-induced up-regulation of nAChRs, presumably
miRNA expression would be down-regulated by nicotine.
To test this idea, mice were chronically treated with nicotine
or saline followed by miRNA expression analysis. Nicotine
induced a general trend of miRNA down-regulation among
the majority of the miRNAs analyzed, consistent with a
role in nicotine-induced nAChR up-regulation (Supplemen-
tal Fig. 2). Statistically significant decreases in expression in
mice chronically treated with nicotine, as compared with sa-
line-treated controls, were observed for seven miRNAs: miR-
FIGURE 2. MREs in human nAChR subunit 3′ UTRs. Six of the
miRNAs that were determined from the large-scale screen to regulate
mouse nAChR 3′ UTRs (Fig. 1, Supplemental Table 1) have potential
MREs in several human nAChR subunit 3′ UTRs. The six miRNAs
are indicated in bold. The seed match site in each human nAChR sub-
unit 3′ UTR is shown in red and is aligned to the seed region of the
miRNA. In the case where a 3′ UTR has multiple predicted MREs,
each site is designated by a number in order of location moving in a
5′–3′ direction.
miRNA regulation of nAChR subunit genes
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200c, miR-201, miR-24, miR-422b, miR-490, miR-491, and
miR-704. In one case, miR-688, there was an apparent in-
crease in expression but this did not reach statistical signifi-
cance. The mechanism by which nicotine alters miRNA
expression is unknown but presumably could occur at several
levels of miRNA biogenesis such as transcription, nuclear
processing, or RISC formation. In addition, nicotine may
change miRNA tailing, editing, methylation, or stability lead-
ing to effects on miRNA expression (Ha and Kim 2014).
miRNA and nAChR expression in the reward pathway
The data presented in Supplemental Figure 2 were generated
fromwhole brains. In order to gain more insight as to the po-
tential role miRNAs may play in nicotine-mediated regula-
tion of nAChR expression, we determined the expression
levels of two miRNAs, miR-494, and miR-542-3p, and their
predicted targets, the α4 and β2 nAChR mRNAs, respectively
(see Fig. 1), within specific regions of the mesocorticolimbic
reward circuitry. These two nAChR subunits are of particular
interest because first, most of the high-affinity nAChRs ex-
pressed within the reward pathway contain the α4 and β2
subunits (Zhao-Shea et al. 2011) and second, both subunits
have been shown to be critical for nicotine-dependence asso-
ciated behaviors (Picciotto et al. 1998; Tapper et al. 2004). As
shown in Figure 3, miR-494 expression was not altered by
chronic nicotine treatment in any of the regions tested, the
nucleus accumbens (NAc), the prefrontal cortex (PFC), or
the ventral tegmental area (VTA). Similarly, α4 nAChR
mRNA expression was not significantly changed following
nicotine treatment (Fig. 3). Interestingly, however, there ap-
pears to be a reciprocal relationship between miR-542-3p
and β2 nAChR mRNA expression levels following chronic
nicotine treatment. In the VTA, miR-542-3p expression
was significantly decreased by nicotine whereas β2 expression
was significantly up-regulated (Fig. 3). β2 expression was also
significantly increased by nicotine in the NAc and PFC,
however, miR-542-3p expression, while trending in a down-
wardmanner, was not significantly different (Fig. 3). Togeth-
er, these data support the contention that miRNAs may
contribute to nicotine-mediated up-regulation of nAChR
expression.
miRNA regulation of endogenous nAChR expression
The experiments presented above demonstrate that a subset
of miRNAs down-regulate nAChR mRNA expression. It
is important to determine if this effect extends to nAChR
protein expression given the functional implications of
such regulation. To address this critical issue, we used the
rat pheochromocytoma cell line, PC12, which expresses rel-
atively high levels of nAChR subunits following nerve growth
factor treatment (Henderson et al. 1994). PC12 cells were
transfected with either miR-542-3p mimic or inhibitor fol-
lowed by 3 d of nerve growth factor treatment and sub-
sequent immunoblotting. Transfection of the miR-542-3p
mimic and inhibitor substantially increased (∼640 × control)
and decreased (∼0.004 × control) miR-542-3p levels, respec-
tively (data not shown). As shown in Figure 4, overexpression
of miR-542-3p led to a statistically significant down-regu-
lation of endogenous β2 nAChR subunit expression. As a
FIGURE 3. Reciprocal relationship between miR-542-3p and nAChR
β2 transcript levels in the mesocorticolimbic reward pathway following
nicotine treatment. RNA was isolated from the indicated brain regions
from animals treated with saline or nicotine as described in Materials
and Methods. qRT-PCR was carried out for miR-494, miR-542-3p,
nAChR α4, and nAChR β2 transcripts as indicated. Student’s t-test
was used for statistical analysis, (∗) P < 0.05, (∗∗) P < 0.01; n = 6.
Hogan et al.
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negative control, α4 subunit expression was measured. The
α4 gene does not contain any known miR-542-3p MREs,
and as expected, there was no effect of miR-542-3p over-ex-
pression on α4 subunit levels (Fig. 4A). Somewhat puzzling
was the lack of an effect of inhibiting miR-542-3p levels on
nAChR expression (Fig. 4B). It may be that endogenous levels
of miR-542-3p are below a certain threshold required for ef-
fects on nAChR expression and therefore, further lowering
those levels with an inhibitor would produce no effect on re-
ceptor expression, an idea that needs to be tested in future
studies.
In summary, we performed a large-scale miRNAome anal-
ysis of the mammalian neuronal nAChR family and have
identified 27 miRNAs as potential regulators of nicotinic re-
ceptor expression. We identified MREs in the nAChR 3′
UTRs that are required for regulation by 14 of the miRNAs.
Furthermore, expression of the majority of the candidate
miRNAs is down-regulated by chronic nicotine treatment,
consistent with a role in nicotine-induced nAChR up-regu-
lation in the brain. Importantly, data are presented indicating
a reciprocal relationship between miR-542-3p and nAChR
β2 mRNA expression in the mesocorticolimbic pathway fol-
lowing nicotine treatment. Finally, overexpression of miR-
542-3p in differentiated PC12 cells led to a statistically signif-
icant decrease in β2 subunit expression. To the best of our
knowledge, this is the first such analysis of the nAChR family
and sets the stage for further studies aimed at a variety of sig-
naling pathways in which the receptors are involved.
An important next step is to extend the study of miRNA
regulation of nAChR expression in vivo and to determine
if that regulation impacts behavior. Indeed, recent reports
have demonstrated that miRNAs are key regulatory factors
in cocaine reinforcement (Hollander et al. 2010; Im et al.
2010) and alcohol tolerance (Pietrzykowski et al. 2008). It
is also important to determine the precise spatial and tempo-
ral expression patterns of the miRNAs as this will have bear-
ing on the molecular mechanisms underlying endogenous
effects of miRNA regulation of nAChR expression. Given
the broad array of diseases in which compromised choliner-
gic signaling is implicated (e.g., Alzheimer’s disease, schizo-
phrenia, nicotine addiction, etc.), our identification of a
novel level of regulation of nicotinic receptor expression is
likely to lead to unique therapeutic targets.
MATERIALS AND METHODS
Bioinformatics
Potential miRNA binding sites were identified using Targetscan
(www.targetscan.org), Microcosm Targets (http://www.ebi.ac.uk/
enright-srv/microcosm/htdocs/targets/v5), and mirDIP (http://oph
id.utoronto.ca/mirDIP/index.jsp). A miRbase Basic Local Align-
ment Search Tool was used to investigate homologous miRNAs be-
tween mouse and human (http://www.mirbase.org/search.shtml).
Multiple Sequence Alignment (MUSCLE) was used to align mouse
and human miRNA binding sites (http://www.ebi.ac.uk/Tools/msa/
muscle/).
Cloning
The 3′ UTRs of the nAChR subunits were amplified frommouse ge-
nomic DNA and cloned into the luciferase expression reporter vec-
tor, pMIR-REPORT Luciferase (Applied Biosystems). The wild-type
α2 3′-UTR luciferase expression construct was generated by ampli-
fying a 2063-bp SpeI/MluI fragment using forward primer: ACTA
GTCCAGGTGAAGGAAGATTGGA and reverse primer: ACGCG
TCTGGAGGGGACGAGTTAATG. The wild-type α3 3′-UTR lucif-
erase expression construct was generated by amplifying a 1655-bp
NaeI/HindIII fragment using forward primer: TATCTAGCCGG
CCCCTTCTCCTTCATGTTCCA and reverse primer: ACGCGT
CTGGAGGGGACGAGTTAATG. The wild-type α4 3′-UTR lucifer-
ase expression construct was generated by amplifying a 2662-bp
SpeI/HindIII fragment using forward primer: TGCTTTACTAGT
CTGTGTTTGCAGGTGAAGGA and reverse primer: TCAGTTAA
GCTTACACATGCCCACAGAGATGA. The wild-type α5 3′-UTR
luciferase expression construct was generated by amplifying a
1159-bp SacI/PmeI fragment using forward primer: ACTTGGAG
CTCACGCTAGGGCTTTTTGTTCC and reverse primer: AGGC
GGTTTAAACGAATATGGACAAGGCGACTGA. The wild-type
FIGURE 4. Over-expression of miR-542-3p down-regulates endoge-
nous nAChR β2 protein levels in differentiated PC12 cells. PC12 cells
were transfected with miR-542-3p mimic (A) or inhibitor (B) and treat-
ed with NGF for 3 d. Controls were transfected with control mimic or
control inhibitor. Proteins were isolated and expression levels were
analyzed by immunoblotting. Representative blots showing nAChR sub-
units and β-actin loading controls are presented above the correspond-
ing graph. Each graph presents the average quantification of nAChR
subunit protein levels for each sample, normalized to the β-actin loading
control. Protein levels of miRNA mimic/inhibitor treated cells (+) are
presented relative to control mimic/inhibitor (−). Student’s t-test was
used for statistical analysis, (∗) P < 0.05; n = 4.
miRNA regulation of nAChR subunit genes
www.rnajournal.org 1895
 Cold Spring Harbor Laboratory Press on January 31, 2018 - Published by rnajournal.cshlp.orgDownloaded from 
α6 3′-UTR luciferase expression construct was generated by ampli-
fying a 2063-bp SpeI/HindIII fragment using forward primer:
TGTCGTACTAGTGGCAGGCAAACATAATAGCA and reverse
primer: CAGACTAAGCTTCCCACTCGGAAAAAGAAATG. The
wild-type α7 3′-UTR luciferase expression construct was generated
by amplifying a 672-bp SacI/HindIII fragment using forward prim-
er: ATCCAGGAGCTCTGCAGTGAGTGGAAGTTTGC and reverse
primer: ATTCATAAGCTTGACCAACTTTCTCCCTGGTG. The
wild-type α9 3′-UTR luciferase expression construct was generated
by amplifying a 850-bp SpeI/HindIII fragment using forward prim-
er: GCCTGAACTAGTAAGGTCGCCAAGGTCATAGA and reverse
primer: TAACTGAAGCTTGGCCAGGACAAAATCTTGAA. The
wild-type α10 3′-UTR luciferase expression construct was generated
by amplifying a 852-bp SpeI/MluI fragment using forward primer:
ATCCAGACTAGTCTCCTGGTACTGGTGCAAGC and reverse
primer: ATAATAACGCGTCCCAACTTCTGGTTGTAGGC. Due
to difficulty in amplifying the entire β2 3′ UTR as a single fragment,
the 3′ UTR was amplified as two overlapping fragments, which were
used to generate two separate luciferase-β2 3′-UTR constructs (β2.1
and β2.2). The wild-type β2.1 3′-UTR luciferase expression con-
struct was generated by amplifying a 2042-bp NaeI/HindIII frag-
ment using forward primer: ATAATAGCCGGCCCAGAACTAC
ACTGCCACGA and reverse primer: TGAGACAAGCTTTCTT
GGGGAACAATTCAGAGA. The wild-type β2.2 3′-UTR luciferase
expression construct was generated by amplifying a 1939-bp SacI/
HindIII fragment using forward primer: ATACTGAGCTCGGCC
ACTGTGCCTATGCTAT and reverse primer: TATAATAAGCTT
CCCTCCCTCTGTCCCTTTAC. The wild-type β3 3′-UTR lucif-
erase expression construct was generated by amplifying a 3205-bp
NaeI/MluI fragment using forward primer: ATTATTGCCGGCC
AGGTTCTTGACCGCATCTT and reverse primer: ACTTACAC
GCGTCCCTCTCTCCACCCATAAGA. The wild-type β4 3′-UTR
luciferase expression construct was generated by amplifying a
2354-bp MluI/PmeI fragment using forward primer: ATCCAGAC
TAGTCTCCTGGTACTGGTGCAAGC and reverse primer: ATAA
TAACGCGTCCCAACTTCTGGTTGTAGGC. For each amplifica-
tion, mouse genomic DNAwas mixed with an excess of the primers,
dNTPs, reaction buffer and Phusion High-Fidelity DNA Polymerase
(New England Biolabs). PCR steps generally included a 1-min initial
denaturing step at 98°C and 35 cycles of the following: a 10-sec 98°C
melting step, a 30-sec 72°C annealing step, and a 30-sec 72°C exten-
sion step. The cycles were followed by a 5-min 72°C final extension
step. These parameters were altered slightly based on the primer
melting temperatures. The PCR products were run on a DNA aga-
rose gel and purified by a commercially available kit (QIAquick Gel
Extraction Kit, Qiagen). Restriction enzyme digest and ligation reac-
tions were accomplished using enzymes and buffers from New
England Biolabs. Ligation products were transformed into compe-
tent Escherichia coli DH5α (Invitrogen) and grown in LB. Plasmids
were isolated for transfection using a commercially available kit
(Plasmid Maxi Prep, Qiagen). The 3′-UTR luciferase expression
constructs were verified by nucleotide sequencing.
Tissue culture and transfection
HEK293T cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM, Mediatech) supplemented with 10% fetal bovine serum.
The cells were seeded at a density of 8000 cells per well into 96-
well plates. After 12 h, the medium was changed to Opti-MEM
and the HEK293T cells were transfected in triplicate with a pmiR-
REPORT Luciferase construct (20 ng) and a pmiR-REPORT-β-gal
Control plasmid (20 ng) (Applied Biosystems) along with miRNA
precursor mimics (10 nM) from Pre-miR miRNA Precursor
Library–Mouse V3 (Ambion). Each experiment included two nega-
tive control miRNA precursor mimics (Ambion). The plasmids and
precursor mimics were introduced into the cells by liposome-medi-
ated transfection using 1 μL of Lipofectamine2000 (Invitrogen) per
well. Twenty-four hours post-transfection, the cells were harvested,
lysed, and assayed for luciferase activity using a commercially avail-
able kit (Promega Corp.) and a LumimarkMicroplate Luminometer
(Bio-Rad). To correct for differences in transfection efficiencies,
luciferase activity in each sample was normalized to the β-galactosi-
dase activity in that same sample. β-Galactosidase activity was mea-
sured using a commercially available kit (Galacto-Light; Tropix,
Inc.). Student’s t-test was used for statistical analysis.
PC12 cells were grown in DMEM supplemented with 10% FBS
and 5% heat-inactivated horse serum. Cells (passage 3–10) were
seeded at a density of 400,000 cells per 60-mm culture dish. After
24 h, medium was changed to Opti-MEM and the cells were trans-
fected in duplicate with 250 pmol of microRNA mimics or inhibi-
tors for miR-494 (mirVana, Ambion) or miR-542-3p (miRIDIAN,
Thermo), using 5 μL of Lipofectamine Reagent (Invitrogen) per
dish. After 24 h, the medium was changed to growth medium con-
taining 100 ng/mL nerve growth factor (NGF). After 48 h, medium
was exchanged with fresh growth medium containing NGF. Cells
were harvested after an additional 24 h and total RNA was isolated
using an RNAqueous Micro Kit (Ambion) for qRT-PCR and pro-
tein was isolated for Western blot as described below.
Site-directed mutagenesis
Site-directed mutagenesis of the nAChR subunit 3′-UTR luciferase
constructs was accomplished by PCR site-directed mutagenesis us-
ing a commercially available kit (QuikChange Site-Directed Muta-
genesis Kit, Stratagene). Two primers were designed per mutant.
The 5′ primerwas designed to substitute three to 4 nt of the predicted
miRNA binding sites. The 3′-UTR luciferase constructs were mixed
with an excess of the primers, dNTPs, reaction buffer, and Pfu DNA
polymerase for PCR. Since the parental DNA is isolated from E. coli
and is thereforemethylated, Dpn I was added to digest all methylated
parental DNA. Themutated plasmids were transformed into compe-
tent E. coli XL1-Blue (Invitrogen), grown in LB and isolated by Plas-
mid Mini Prep (Qiagen). They were then transformed into
competent E. coli DH5α and grown in LB. Plasmids were isolated
for transfection using a commercially available kit (Plasmid Maxi
Prep, Qiagen). Mutations were verified by nucleotide sequencing.
Animals
Adult male C57BL/6J mice (Jackson Laboratory, West Grove, PA,
USA) were used in the experiments. Mice were anesthetized by an
intraperitoneal injection of a ketamine/xylazine solution (0.1 mL/
10 g body weight, 10 mg/mL ketamine, 1 mg/mL xylazine). Osmotic
minipumps (Alzet) containing saline or nicotine hydrogen tartrate
solutions were implanted subcutaneously. Mice received a dose of
24 mg/kg/d (nicotine base) for 20–24 d. Mice were culled by cervical
dislocation followed by decapitation after which the brains were
quickly dissected. All experiments were conducted in accordance
with the guidelines for care and use of laboratory animals provided
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by the National Research Council (2010) as well as with an approved
animal protocol from the Institutional Animal Care and Use
Committee of the University of Massachusetts Medical School.
Quantitative reverse transcription-polymerase
chain reactions
For whole-brain experiments (Supplemental Fig. 2), total RNA was
isolated using a mirVana Kit (Ambion). For region-specific experi-
ments (Fig. 3), brains were removed and placed on glass slides and
snap-frozen in liquid nitrogen. Serial coronal sections (1 mm) were
prepared and the PFC, NAc, and VTA were isolated using tissue
punches (Harris UNI-CORE, 1.0 mm; Electron Microscopy Scienc-
es). Total RNA was isolated from the samples using a Micro Scale
RNA Isolation Kit (Ambion). miRNAs were reverse-transcribed
using a miRNA TaqMan Reverse Transcription Kit (Applied Biosys-
tems). Quantitative reverse transcription-polymerase chain reac-
tions (qRT-PCR) were done using an Applied Biosystems 7500
Real-Time System and miRNA TaqMan assays (Applied Biosys-
tems). Samples containing no reverse transcriptase were used as
negative controls. Relative gene expression was calculated using
the 2−ΔΔCt method (Livak and Schmittgen 2001). Expression values
are relative to sno202, a small nucleolar RNA not regulated by nic-
otine. Samples were analyzed in triplicate. Student’s t-test was used
for statistical analysis.
Immunoblotting
PC12 cells were grown and transfected as described above. Cells were
washed twice in coldphosphate-buffered saline (PBS) andpelleted by
centrifugation.To isolateproteins, cellswere resuspended in150–200
μLRIPA buffer (50mMTris–HCl pH7.4, 150mMNaCl, 1%NP-40,
0.5% sodium deoxycholate, 0.1% SDS; Boston Bioproducts) supple-
mented with protease (Complete, EDTA-free; Roche) and phospha-
tase (Phos-Stop; Roche) inhibitors. After rotating for 1 h at 4°C, cell
debriswas pelletedby centrifugation at13,000g for 30min at4°C.The
supernatantwas removedand stored at−80°C.Protein concentration
was determined by Bradford Assay. Protein (40 μg) was added to re-
ducing SDS-sample buffer (375 mM Tris HCl pH 6.8, 9% SDS, 50%
glycerol, 9% β-mercaptoethanol, 0.03% bromophenol blue; Boston
Bioproducts) and boiled for 2 min. Protein samples were then sepa-
rated by 8%SDS-PAGE and electroblotted onto nitrocellulosemem-
branes in transfer buffer (25 mM Tris, 192 mM glycine, 20%
methanol). Membranes were blocked in 5% nonfat dry milk
(Blotting grade nonfat dry milk; Bio-Rad) in PBS with Tween-20
(PBST) for 1 h at room temperature.Membranes were cut just below
50 kDa and the upper half was incubatedwith 1 μg/mL anti-AChR α4
(sc-5591; Santa Cruz) or anti-AChR β2 (sc-11372; Santa Cruz) in
blocking solution overnight at 4°C. These antibodies were used based
on their successful use as reported by others (Kabbani et al. 2007;
Wecker et al. 2010; Shimizu et al. 2011). As loading control, β-actin
was detected in the lower half of the membrane using 1 μg/mL
anti-actin antibody (sc-56459; Santa Cruz) in blocking solution.
Blots were incubated in HRP-linked secondary antibody for the
anti-AChR (0.8 μg/mL, sc-2020; Santa Cruz) or anti-actin antibodies
(5 ng/mL Cat# 32430; Thermo) for 1.5 h at room temperature. After
application of SuperSignal West Dura Chemiluminescent Substrate
(Thermo) to the blots, proteins were visualized using a VersaDoc
MP 5000 Imaging System (Bio-Rad) at various exposure times.
Membranes were stripped using Restore Western Blot Stripping
Buffer (Thermo) for detection of the other nAChR subunit.
Protein band intensity was quantified using ImageJ software and
the nAChR subunit protein levels for each sample were normalized
to the β-actin loading control. Protein levels ofmiRNAmimic- or in-
hibitor-treated cells are presented relative to controls. Student’s t-test
was used for statistical analysis.
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